We are live on ! Find out more
TGI

TRV GP II Portfolio holdings

AUM $1.34M
1-Year Est. Return 67.55%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
AUM
$170M
AUM Growth
-$6.01M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPMC
1
DELISTED
Blueprint Medicines
BPMC
$68.6M 40.27%
878,875
JNCE
2
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$66.5M 39.03%
10,230,349
ALNA
3
DELISTED
Allena Pharmaceuticals
ALNA
$30M 17.6%
2,790,964
SAGE
4
DELISTED
Sage Therapeutics
SAGE
$5.28M 3.1%
37,362

Similar funds

TRV GP II's Q3 2018 Portfolio in Review

As of Q3 2018, TRV GP II held 4 positions worth $170M, down 3.4% from $176M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. TRV GP II opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP II's ten largest holdings make up 100% of its $170M portfolio in Q3 2018.
  • TRV GP II opened 0 new positions and closed 0 in Q3 2018.
  • TRV GP II's portfolio value fell 3.4% quarter-over-quarter to $170M.

Based on TRV GP II's 13F filing for Q3 2018, filed 29 Oct 2018.